NEWS + UPDATES

SAN ANTONIO (December 19, 2022) – A Sudan ebolavirus vaccine and antibody therapeutic tested at Texas Biomedical Research Institute have been sent to Uganda as part of efforts to control the outbreak...

Novavax expands global options for prevention of disease and severe outcomes

SAN ANTONIO (July 28, 2022) – The Food and Drug Administration has authorized the Novavax COVID-19 Vaccine, Adjuvanted for...

SAN ANTONIO (Jan. 13, 2022) – After nearly 13 years in the Army as a laboratory technician, Staff Sergeant Jackie Poinsette was ready...

Scientists join collaborators from around the nation to combat COVID-19

San Antonio, Texas (October 15, 2020) - Scientists at Texas Biomedical Research Institute (Texas Biomed) have been selected to...

In mid-August 2019, human clinical trials were halted in the current Ebola epidemic that has claimed more than 2,100 lives in Africa. The findings resulted in...